LivaNova PLC
NASDAQ:LIVN
LivaNova PLC
Cash & Cash Equivalents
LivaNova PLC
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LivaNova PLC
NASDAQ:LIVN
|
Cash & Cash Equivalents
$309.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
44%
|
CAGR 10-Years
12%
|
|
Smith & Nephew PLC
LSE:SN
|
Cash & Cash Equivalents
$302m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Cash & Cash Equivalents
$100m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cash & Cash Equivalents
£7.7m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
12%
|
|
Angle PLC
LSE:AGL
|
Cash & Cash Equivalents
£22.2m
|
CAGR 3-Years
78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Creo Medical Group PLC
LSE:CREO
|
Cash & Cash Equivalents
£13.1m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LivaNova PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
309.2m
USD
Based on the financial report for Mar 31, 2024, LivaNova PLC's Cash & Cash Equivalents amounts to 309.2m USD.
What is LivaNova PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
12%
Over the last year, the Cash & Cash Equivalents growth was 44%. The average annual Cash & Cash Equivalents growth rates for LivaNova PLC have been 7% over the past three years , 44% over the past five years , and 12% over the past ten years .